| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 05/06/2004 | US20040087790 Amidation of an alpha-keto formic acid with an alpha-carboxy alkylenimine; reducing the ketoamide formed to a hydroxyamide; and cyclizing |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | US20040087569 N-heterocyclic bicyclic lactone compounds |
| 05/06/2004 | US20040087566 Enzyme inhibitors; anticancer agents |
| 05/06/2004 | EP1415992A1 Diamine derivatives |
| 05/06/2004 | EP1414826A1 Therapeutically useful tetracyclic ligands |
| 05/06/2004 | EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | EP1414438A1 Antineoplastic combinations |
| 05/06/2004 | EP1088825B1 Enantiomerically pure substituted oxaaza compounds, salts of the same, and processes for the preparation of both |
| 05/06/2004 | CA2503520A1 Process for producing optically active sulfoxide |
| 05/06/2004 | CA2502488A1 Novel substituted[1,4]benzodioxino[2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/05/2004 | CN1494422A Use of GABAA inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin E for treatment of cognitive disorders |
| 05/05/2004 | CN1493573A Production method of rifampicin isomer, rifampicin derivative and its mixture |
| 05/05/2004 | CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase |
| 05/04/2004 | US6730677 Treating memory impairment; enhance excitatory synaptic activity in order to restore an imbalance between brain subregions, as in treatment of schizophrenia or schizophreniform behavior. |
| 05/04/2004 | US6730497 Enzymatically converting a 3-thiolated cephalosporin c into a 3-thiolated-alpha-ketoadipyl-7-aminocephalosporanic acid derivative of use in the preparation of cephalosporin c antibiotics and derivatives thereof |
| 04/29/2004 | WO2004035592A1 Chemical intermediate |
| 04/29/2004 | WO2004035536A2 Azo compounds for type i phototherapy |
| 04/29/2004 | WO2004034961A2 Antimicrobial agents and uses thereof |
| 04/29/2004 | WO2004014389A8 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 04/29/2004 | WO2003099823A3 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2003045919A3 Process for the synthesis of amine ethers from secondary amino oxides and uses |
| 04/29/2004 | WO2002085909A8 9-deazaguanine derivatives as inhibitors of gsk-3 |
| 04/29/2004 | US20040082787 Chemical compounds |
| 04/29/2004 | US20040082639 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents |
| 04/29/2004 | US20040082576 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/29/2004 | US20040082574 Compounds with the bicyclo[4.2.1]nonane system for the treatment of flavivridae infections |
| 04/29/2004 | US20040082573 Anxiolytic agents with reduced sedative and ataxic effects |
| 04/29/2004 | US20040082555 Use of gaba, inverse agonists in combination with nicotine receptor partial agonist, estrogen, selective estrogen modulators, or vitamin E for the treatment of cognitive disorders |
| 04/29/2004 | US20040082515 Regulation of biological events using novel compounds |
| 04/29/2004 | CA2502211A1 Azo compounds for type i phototherapy |
| 04/29/2004 | CA2501413A1 Chemical intermediate |
| 04/28/2004 | EP1413581A1 Rapamycin derivatives |
| 04/28/2004 | EP1412363A1 Gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411932A1 Substituted oxazolidinones for combinational therapy |
| 04/28/2004 | EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | CN1492872A Tricycle quinolinone and tricycle quinoline as androgen receptor modulator compounds |
| 04/28/2004 | CN1492871A Isoxazoline derivatives as anti-depressants |
| 04/28/2004 | CN1492759A Device and method for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
| 04/28/2004 | CN1491951A Intermediate of azepine |
| 04/28/2004 | CN1147493C Oxazolo, thiazole and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof and pharmaceutical composition containing them |
| 04/28/2004 | CN1147489C New bicyclo aminopyrazineone compound, its production process and medical composition containing them |
| 04/28/2004 | CN1147483C Adamantane derivatives |
| 04/28/2004 | CN1147317C Combination of tyrosine kinase inhibitor and chemical castration and its use in pharmaceutical production |
| 04/27/2004 | US6727273 Therapy for osteoporosis, anticancer agents |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727247 Adenosine receptor ligands in a method of treatment, control, or prevention of central nervous system disorders |
| 04/27/2004 | US6726923 Prosthetic device placed on the outside surface of the vessel or graft which then elutes antiproliferatives from a matrix |
| 04/27/2004 | US6726911 Biologically active compounds of Ganoderma pfeifferi DSM 13239 |
| 04/22/2004 | WO2004033652A2 Inhibitors of fatty acid amide hydrolase |
| 04/22/2004 | WO2004033463A1 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES |
| 04/22/2004 | WO2003051300A8 Metal complexes and formulations of rifamycin analogues and uses therof |
| 04/22/2004 | WO2003051299A8 Sulfhydryl rifamycins and uses thereof |
| 04/22/2004 | US20040077868 Process |
| 04/22/2004 | US20040077701 Pyrazole derivates for treatment of osteoporosis, breast and endometrial cancers, atherosclerosis, and Alzheimer*s disease |
| 04/22/2004 | US20040077680 Ureaacylated indazole, benzisoxazole, or benzisothiazole derivative with monocyte chemoattractant protein inhibitors; antiinflammatory agents; autoimmune diseases; arthritis, asthma, atherosclerosis, diabetes |
| 04/22/2004 | US20040077675 Compounds and methods for inhibiting MRP1 |
| 04/22/2004 | US20040077671 Sorbitol dehydrogenase inhibitors |
| 04/22/2004 | US20040077634 Treatment of diseases characterized by excessive or insufficient cell death |
| 04/22/2004 | US20040077533 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 04/22/2004 | CA2501575A1 Inhibitors of fatty acid amide hydrolase |
| 04/21/2004 | EP1409489A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 04/21/2004 | EP1409467A1 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
| 04/21/2004 | EP1212331B1 28-epirapalogs |
| 04/21/2004 | EP1187828B1 Quinoline derivatives as antibacterials |
| 04/21/2004 | EP1033130B1 Inhibitor of urokinase production and of angiogenesis and its therapeutic use |
| 04/21/2004 | CN1491226A Epindolidione pigments |
| 04/20/2004 | US6723860 7a-alkoxy-4H-pyrano[3,2-d]-oxazol-2(3H)-one and process for producing the same |
| 04/20/2004 | US6723844 Forming alkali metal salt of the acid with the hydroxide base, esterification with methyl p-toluenesulfonate; eliminates both the need for column chromatography and the use of dimethylsulfate as methylating agent |
| 04/20/2004 | CA2031486C Synergistins preparation process |
| 04/15/2004 | WO2004031195A1 Tricyclic tetrahydroquinoline antibacterial agents |
| 04/15/2004 | US20040073024 Phosphorus-containing compounds and uses thereof |
| 04/14/2004 | EP1408042A1 Novel isoxazolopyridone derivatives and use thereof |
| 04/14/2004 | EP1406700A1 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 04/14/2004 | EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 04/14/2004 | EP1406619A1 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 04/14/2004 | EP1073662B1 Process for preparing (-)pyridobenzoxazine carboxylic acid derivatives |
| 04/14/2004 | EP1042315B1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 04/14/2004 | EP0925298B1 Substituted 6,6-hetero-bicyclic derivatives |
| 04/14/2004 | EP0921800B1 Substituted biphenyl isoxazole sulfonamides |
| 04/13/2004 | US6720328 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) |
| 04/13/2004 | US6720316 Therapeutic 5-HT ligand compounds |
| 04/13/2004 | US6720188 Monitoring the concentration of arginine in sample; obtain sample, incubate with binding particle, determine arginine concentration in sample |
| 04/08/2004 | WO2004014893A3 Antimicrobial aza-bicyclic derivates, their compositions and uses |
| 04/08/2004 | WO2004014361A9 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 04/08/2004 | WO2004009564A3 Co-surfactants based on aldehydes |
| 04/08/2004 | WO2003082832A3 Anxiolytic agents with reduced sedative and ataxic effects |
| 04/08/2004 | WO2003057667B1 Strapped and modified bis (benzimidazole) diamides for asymmetric catalysts and other applications |
| 04/08/2004 | WO2003035652A9 A PROCESS FOR PREPARING ENANTIOMERICALLY PURE α-PHENYL-α-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)-ACETIC ACID DERIVATIVES |
| 04/08/2004 | US20040067997 Respiratory syncytial virus |
| 04/08/2004 | US20040067994 Grampositive, gramnegative bacteria therapy |
| 04/08/2004 | US20040067991 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 04/08/2004 | US20040067549 A process for the preparation of 3-thiolated derivatives of 3-acetoxy-methyl-7-amino-ceph-3-em-carboxylic acid; antibiotics |
| 04/07/2004 | EP1405852A1 Diamine derivatives |
| 04/07/2004 | EP1404684A1 New picolinamine derivatives and their use a fungicides |
| 04/07/2004 | EP1404682A1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48 |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1307457B1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 04/07/2004 | EP1292299B1 New use of citreamicins |